Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder

NCT00659347 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: DOV 21, 947
DRUG: Placebo

Sponsor

DOV Pharmaceutical, Inc.